57.59
Inspire Medical Systems Inc stock is traded at $57.59, with a volume of 634.69K.
It is up +2.02% in the last 24 hours and up +4.42% over the past month.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
See More
Previous Close:
$56.45
Open:
$56.99
24h Volume:
634.69K
Relative Volume:
0.52
Market Cap:
$1.66B
Revenue:
$911.98M
Net Income/Loss:
$145.42M
P/E Ratio:
11.60
EPS:
4.9642
Net Cash Flow:
$78.48M
1W Performance:
+6.61%
1M Performance:
+4.42%
6M Performance:
-26.18%
1Y Performance:
-61.66%
Inspire Medical Systems Inc Stock (INSP) Company Profile
Name
Inspire Medical Systems Inc
Sector
Industry
Phone
763-957-5037
Address
5500 WAYZATA BLVD, GOLDEN VALLEY
Compare INSP vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
INSP
Inspire Medical Systems Inc
|
57.59 | 1.66B | 911.98M | 145.42M | 78.48M | 4.9642 |
|
ABT
Abbott Laboratories
|
96.81 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
|
SYK
Stryker Corp
|
343.32 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.19 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
64.23 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
80.99 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Inspire Medical Systems Inc Stock (INSP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Feb-12-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-12-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-27-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-22-26 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-22-26 | Downgrade | Truist | Buy → Hold |
| Dec-08-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-02-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-26-25 | Upgrade | Truist | Hold → Buy |
| Nov-25-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Nov-24-25 | Upgrade | Stifel | Hold → Buy |
| Nov-04-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-24-25 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-25 | Downgrade | UBS | Buy → Neutral |
| Sep-02-25 | Initiated | Evercore ISI | Outperform |
| Aug-05-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Aug-05-25 | Downgrade | Truist | Buy → Hold |
| Nov-20-24 | Upgrade | BofA Securities | Neutral → Buy |
| May-08-24 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-19-24 | Initiated | RBC Capital Mkts | Outperform |
| Mar-19-24 | Initiated | Morgan Stanley | Overweight |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-19-24 | Initiated | Jefferies | Buy |
| Jan-02-24 | Downgrade | Stifel | Buy → Hold |
| Dec-13-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-14-23 | Initiated | Mizuho | Buy |
| Mar-29-23 | Initiated | UBS | Buy |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Dec-13-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-15-20 | Downgrade | Goldman | Buy → Neutral |
| Nov-03-20 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-03-20 | Upgrade | Oppenheimer | Underperform → Perform |
| Sep-22-20 | Initiated | JP Morgan | Overweight |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-06-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-15-20 | Initiated | Goldman | Buy |
| Jun-18-20 | Reiterated | Piper Sandler | Overweight |
| May-18-20 | Initiated | Lake Street | Buy |
| Apr-28-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Apr-09-20 | Initiated | Piper Sandler | Overweight |
| Jan-28-20 | Initiated | Oppenheimer | Underperform |
| Jan-27-20 | Initiated | Oppenheimer | Underperform |
| Nov-06-19 | Upgrade | Berenberg | Sell → Hold |
| Feb-05-19 | Initiated | Dougherty & Company | Buy |
| Nov-28-18 | Initiated | Berenberg | Sell |
| Oct-29-18 | Initiated | Leerink Partners | Outperform |
| May-29-18 | Initiated | Guggenheim | Buy |
| May-29-18 | Initiated | Stifel | Buy |
| May-29-18 | Initiated | Wells Fargo | Outperform |
View All
Inspire Medical Systems Inc Stock (INSP) Latest News
Hedge funds view Inspire Medical (INSP) as one of the best small-cap healthcare stocks - MSN
Director at Inspire Medical Systems (INSP) receives 307-share stock grant - Stock Titan
Inspire Medical (INSP) director gets 342-share stock fee grant - Stock Titan
Director Ellis receives 518 Inspire Medical (INSP) shares as fees - Stock Titan
Director Tansey receives 308 Inspire Medical (INSP) shares as fees - Stock Titan
Inspire Sleep Apnea Lawsuit Alleges Man Suffered Hours of Electrical Shocks From Device - AboutLawsuits.com
Inspire Medical Systems (NYSE:INSP) Cut to "Hold" at Zacks Research - MarketBeat
Inspire Medical Systems (NYSE:INSP) Price Target Cut to $64.00 by Analysts at Truist Financial - MarketBeat
Truist Financial Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Cuts Target Price to $64 - 富途牛牛
Inspire Medical Systems, Inc. (NYSE:INSP) Q2 2025 Earnings Call Transcript - MSN
Is It Too Late to Buy Inspire Medical Systems Inc (INSP) After 3 - GuruFocus
INSP Stock Price, Quote & Chart | INSPIRE MEDICAL SYSTEMS INC (NYSE:INSP) - ChartMill
INSP Maintained by Mizuho -- Price Target Lowered to $70 - GuruFocus
Inspire Medical Systems Outperforms Alternate Health in Key Metrics - National Today
Here's why you should add Inspire Medical stock to your portfolio now - MSN
INSP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Why is Inspire (INSP) down 2.4% since last earnings report? - MSN
A Look at Inspire Medical Systems Inc (INSP) After 4.7% Decline -- GF Value $240.40 vs Price $54.02 - GuruFocus
(INSP) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Today's Analyst Ratings for INSP: Key Changes and Updates | INSP Stock News - GuruFocus
Inspire Medical Systems (NYSE:INSP) Price Target Lowered to $70.00 at Stifel Nicolaus - MarketBeat
Stifel cuts Inspire Medical stock price target on reimbursement concerns By Investing.com - Investing.com Canada
Has Inspire Medical Systems (INSP) Fallen Too Far After A 60.8% One-Year Slide? - Sahm
Deadline Soon: Inspire Medical Systems, Inc. (INSP) Shareholders - The National Law Review
Inspire Medical Systems (NYSE:INSP) Shares Up 7.7%Here's Why - MarketBeat
Inspire Medical Systems, Inc. (NYSE:INSP) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Consider Including Inspire Medical Stock in Your Portfolio Right Now—Here's Why - Bitget
Here's Why You Should Add Inspire Medical Stock to Your Portfolio Now - Zacks Investment Research
Inspire Medical Systems Inc. R (2DR.MU) Q1 FY2025 earnings call transcript - Yahoo Finance
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off - Yahoo Finance
Inspire Medical Systems, Inc. $INSP Shares Bought by Rheos Capital Works Inc. - MarketBeat
Inspire Medical (INSP) is Gaining Strength from Its Product Offering and Differentiation - Insider Monkey
Evercore Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Cuts Target Price to $62 - Moomoo
Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026 - Bitget
Inspire Medical to detail Q1 results and business update May 4 - Stock Titan
Aberdeen Group plc Acquires 64,561 Shares of Inspire Medical Systems, Inc. $INSP - MarketBeat
A Look At Inspire Medical Systems (INSP) Valuation After CMS Reimbursement Clarity And Rising Hedge Fund Interest - Sahm
Inspire Medical Systems Insiders Sell US$1.3m Of Stock, Possibly Signalling Caution - Moomoo
Inspire Medical Systems, Inc. (INSP) stock price, news, quote and history - Yahoo Finance Singapore
Inspire Medical Systems, Inc. (INSP) latest stock news and headlines - Yahoo Finance Singapore
Inspire Medical Systems, Inc. $INSP Shares Bought by SG Americas Securities LLC - marketbeat.com
Inspire Medical Systems, Inc. $INSP Stock Position Increased by Banque Pictet & Cie SA - MarketBeat
MMSI Expands Oncology Offering With View Point Medical Acquisition - TradingView — Track All Markets
Inspire Medical Systems, Inc. (INSP) Stock Forecasts - Yahoo Finance
Inspire Medical Systems (INSP) Valuation Reset After Share Price Weakness Attracts Fresh Fundamental Scrutiny - Yahoo Finance
Is Inspire Medical Systems (INSP) Attractive After A 67% One-Year Share Price Slump? - Yahoo Finance
Hedge Funds View Inspire Medical (INSP) as One of the Best Small-Cap Healthcare Stocks - Insider Monkey
Inspire Medical Systems Inc Stock (INSP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):